Literature DB >> 27742835

The TORC1-activated Proteins, p70S6K and GRB10, Regulate IL-4 Signaling and M2 Macrophage Polarization by Modulating Phosphorylation of Insulin Receptor Substrate-2.

Kristi J Warren1, Xi Fang1, Nagaraj M Gowda1, Joshua J Thompson1, Nicola M Heller2.   

Abstract

Lung M2 macrophages are regulators of airway inflammation, associated with poor lung function in allergic asthma. Previously, we demonstrated that IL-4-induced M2 gene expression correlated with tyrosine phosphorylation of the insulin receptor substrate-2 (IRS-2) in macrophages. We hypothesized that negative regulation of IRS-2 activity after IL-4 stimulation is dependent upon serine phosphorylation of IRS-2. Herein, we describe an inverse relationship between tyrosine phosphorylation (Tyr(P)) and serine phosphorylation (Ser(P)) of IRS-2 after IL-4 stimulation. Inhibiting serine phosphatase activity increased Ser(P)-IRS-2 and decreased Tyr(P)-IRS-2 leading to reduced M2 gene expression (CD200R, CCL22, MMP12, and TGM2). We found that inhibition of p70S6K, downstream of TORC1, resulted in diminished Ser(P)-IRS-2 and prolonged Tyr(P)-IRS-2 as well. Inhibition of p70S6K increased expression of CD200R and CCL22 indicating that p70S6K negatively regulates some, but not all, human M2 genes. Knocking down GRB10, another negative regulatory protein downstream of TORC1, enhanced both Tyr(P)-IRS-2 and increased expression of all four M2 genes. Furthermore, GRB10 associated with IRS-2, NEDD4.2 (an E3-ubiquitin ligase), IL-4Rα, and γC after IL-4 stimulation. Both IL-4Rα and γC were ubiquitinated after 30 min of IL-4 treatment, suggesting that GRB10 may regulate degradation of the IL-4 receptor-signaling complex through interactions with NEDD4.2. Taken together, these data highlight two novel regulatory proteins that could be therapeutically manipulated to limit IL-4-induced IRS-2 signaling and polarization of M2 macrophages in allergic inflammation.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  GRB10; IL-4; IRS-2; S6 kinase; allergy; asthma; macrophage; mammalian target of rapamycin (mTOR); p70S6K

Mesh:

Substances:

Year:  2016        PMID: 27742835      PMCID: PMC5122764          DOI: 10.1074/jbc.M116.756791

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  42 in total

1.  Insulin-induced serine phosphorylation of IRS-2 via ERK1/2 and mTOR: studies on the function of Ser675 and Ser907.

Authors:  Louise Fritsche; Sabine S Neukamm; Rainer Lehmann; Elisabeth Kremmer; Anita M Hennige; Andrea Hunder-Gugel; Martin Schenk; Hans-Ulrich Häring; Erwin D Schleicher; Cora Weigert
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-11-23       Impact factor: 4.310

2.  Phosphoproteomic analysis identifies Grb10 as an mTORC1 substrate that negatively regulates insulin signaling.

Authors:  Yonghao Yu; Sang-Oh Yoon; George Poulogiannis; Qian Yang; Xiaoju Max Ma; Judit Villén; Neil Kubica; Gregory R Hoffman; Lewis C Cantley; Steven P Gygi; John Blenis
Journal:  Science       Date:  2011-06-10       Impact factor: 47.728

3.  Positive and negative regulatory role of insulin receptor substrate 1 and 2 (IRS-1 and IRS-2) serine/threonine phosphorylation.

Authors:  Michael W Greene; Robert S Garofalo
Journal:  Biochemistry       Date:  2002-06-04       Impact factor: 3.162

4.  Characterization of PF-4708671, a novel and highly specific inhibitor of p70 ribosomal S6 kinase (S6K1).

Authors:  Laura R Pearce; Gordon R Alton; Daniel T Richter; John C Kath; Laura Lingardo; Justin Chapman; Catherine Hwang; Dario R Alessi
Journal:  Biochem J       Date:  2010-10-15       Impact factor: 3.857

5.  Rapamycin unbalances the polarization of human macrophages to M1.

Authors:  Alessia Mercalli; Ines Calavita; Erica Dugnani; Antonio Citro; Elisa Cantarelli; Rita Nano; Raffaella Melzi; Paola Maffi; Antonio Secchi; Valeria Sordi; Lorenzo Piemonti
Journal:  Immunology       Date:  2013-10       Impact factor: 7.397

6.  NEDD4-2 associates with gamma(c) and regulates its degradation rate.

Authors:  Valérie Malardé; Richard Proust; Alice Dautry-Varsat; Franck Gesbert
Journal:  Biochem Biophys Res Commun       Date:  2009-07-15       Impact factor: 3.575

Review 7.  Respiratory medicine - genetic base for allergy and asthma.

Authors:  Aristea Binia; Michael Kabesch
Journal:  Swiss Med Wkly       Date:  2012-08-22       Impact factor: 2.193

8.  An IL-4 receptor region containing an insulin receptor motif is important for IL-4-mediated IRS-1 phosphorylation and cell growth.

Authors:  A D Keegan; K Nelms; M White; L M Wang; J H Pierce; W E Paul
Journal:  Cell       Date:  1994-03-11       Impact factor: 41.582

9.  Type I IL-4Rs selectively activate IRS-2 to induce target gene expression in macrophages.

Authors:  Nicola M Heller; Xiulan Qi; Ilkka S Junttila; Kari Ann Shirey; Stefanie N Vogel; William E Paul; Achsah D Keegan
Journal:  Sci Signal       Date:  2008-12-23       Impact factor: 8.192

Review 10.  Regulation of insulin sensitivity by serine/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2.

Authors:  K D Copps; M F White
Journal:  Diabetologia       Date:  2012-08-08       Impact factor: 10.122

View more
  12 in total

1.  DNA methylation in nasal epithelium, atopy, and atopic asthma in children: a genome-wide study.

Authors:  Erick Forno; Ting Wang; Cancan Qi; Qi Yan; Cheng-Jian Xu; Nadia Boutaoui; Yueh-Ying Han; Daniel E Weeks; Yale Jiang; Franziska Rosser; Judith M Vonk; Sharon Brouwer; Edna Acosta-Perez; Angel Colón-Semidey; María Alvarez; Glorisa Canino; Gerard H Koppelman; Wei Chen; Juan C Celedón
Journal:  Lancet Respir Med       Date:  2018-12-21       Impact factor: 30.700

2.  Sex differences in M2 polarization, chemokine and IL-4 receptors in monocytes and macrophages from asthmatics.

Authors:  Mireya Becerra-Díaz; Andrew D Lerner; Diana H Yu; Jeffrey P Thiboutot; Mark C Liu; Lonny B Yarmus; Sonali Bose; Nicola M Heller
Journal:  Cell Immunol       Date:  2020-12-06       Impact factor: 4.178

Review 3.  Regulation of Metabolic Disease-Associated Inflammation by Nutrient Sensors.

Authors:  Alex S Yamashita; Thiago Belchior; Fábio S Lira; Nicolette C Bishop; Barbara Wessner; José C Rosa; William T Festuccia
Journal:  Mediators Inflamm       Date:  2018-07-04       Impact factor: 4.711

Review 4.  Aging, Melatonin, and the Pro- and Anti-Inflammatory Networks.

Authors:  Rüdiger Hardeland
Journal:  Int J Mol Sci       Date:  2019-03-11       Impact factor: 5.923

5.  Notch signaling increases PPARγ protein stability and enhances lipid uptake through AKT in IL-4-stimulated THP-1 and primary human macrophages.

Authors:  Naunpun Sangphech; Pornlapat Keawvilai; Tanapat Palaga
Journal:  FEBS Open Bio       Date:  2020-04-26       Impact factor: 2.693

Review 6.  New perspectives on the regulation of type II inflammation in asthma.

Authors:  Mireya Becerra-Díaz; Marsha Wills-Karp; Nicola M Heller
Journal:  F1000Res       Date:  2017-06-28

Review 7.  IL-4 and IL-13 Receptor Signaling From 4PS to Insulin Receptor Substrate 2: There and Back Again, a Historical View.

Authors:  Achsah D Keegan; Jose Zamorano; Aleksander Keselman; Nicola M Heller
Journal:  Front Immunol       Date:  2018-05-15       Impact factor: 7.561

8.  High miR-100 expression is associated with aggressive features and modulates TORC1 complex activation in lung carcinoids.

Authors:  Ida Rapa; Arianna Votta; Gaia Gatti; Stefania Izzo; Nicola Lo Buono; Elisa Giorgio; Simona Vatrano; Francesca Napoli; Aldo Scarpa; Giorgio Scagliotti; Mauro Papotti; Marco Volante
Journal:  Oncotarget       Date:  2018-06-08

9.  Early Developmental Exposure to General Anesthetic Agents in Primary Neuron Culture Disrupts Synapse Formation via Actions on the mTOR Pathway.

Authors:  Jing Xu; R Paige Mathena; Michael Xu; YuChia Wang; CheJui Chang; Yiwen Fang; Pengbo Zhang; C David Mintz
Journal:  Int J Mol Sci       Date:  2018-07-26       Impact factor: 5.923

Review 10.  Role of mTOR in Glucose and Lipid Metabolism.

Authors:  Zhuo Mao; Weizhen Zhang
Journal:  Int J Mol Sci       Date:  2018-07-13       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.